When Can We Rely on Real‐World Evidence to Evaluate New Medical Treatments?

Concerns regarding both the limited generalizability and the slow pace of traditional randomized trials have led to calls for greater use of real‐world evidence (RWE) in the evaluation of new treatments or products. The RWE label has been used to refer to a variety of departures from the methods of...

Descripción completa

Detalles Bibliográficos
Autores principales: Simon, Gregory E., Platt, Richard, Watanabe, Jonathan H., Bindman, Andrew B., John London, Alex, Horberg, Michael, Hernandez, Adrian, Califf, Robert M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
White Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251042/
https://www.ncbi.nlm.nih.gov/pubmed/33895994
http://dx.doi.org/10.1002/cpt.2253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251042/
https://www.ncbi.nlm.nih.gov/pubmed/33895994
http://dx.doi.org/10.1002/cpt.2253

Ejemplares similares